BUPIVACAINE HYDROCHLORIDE ANHYDROUS
UNII AKA908P8J1

Substance Identification & Data

This profile provides standardized clinical and technical data for Bupivacaine Hydrochloride Anhydrous, uniquely identified by the FDA Unique Ingredient Identifier (UNII) AKA908P8J1.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 18010-40-7 and the RxNorm Concept ID (RxCUI) 1375412. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

AKA908P8J1

CAS Registry Number

18010-40-7

RxNorm Concept ID

1375412

Detailed Substance Profile

Preferred Name

BUPIVACAINE HYDROCHLORIDE ANHYDROUS

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

AKA908P8J1

The specific atomic composition represented as a molecular structure string.

InChIKey

C18H28N2O.ClH

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

SIEYLFHKZGLBNX-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C217770

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

64737

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(Nc1c(cccc1C)C)(C2N(CCCC)CCCC2)=O.Cl

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bupivacaine Hydrochloride Anhydrous. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.